Skip to content

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study in Germany and Italy, Third Wave (CLIMATE-III)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06890208
Acronym
CLIMATE-III
Enrollment
176
Registered
2025-03-21
Start date
2025-06-11
Completion date
2025-09-12
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Arrhythmias, Cardiac, Asthma, Coronary Disease, Depressive Disorder, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Ischemic Attack, Transient, Myocardial Infarction, Peripheral Artery Disease, Peripheral Nervous System Diseases, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Schizophrenia, Stroke

Brief summary

The CLIMATE-III Observational Study examines to what extent chronically ill patients experience adverse health effects because of heat and whether the patients' specific health behavior, somatosensory amplification, risk and benefit perception, self-efficacy, health literacy, and the degree of urbanisation of the patients' administration district are associated with these effects. Study participants from Germany and Italy will be included in the sample.

Detailed description

The CLIMATE-III Observational Study aims to analyse to what extent chronically ill patients experience adverse health effects because of heat and whether the patients' specific health behavior, self-efficacy, or other factors are associated with these effects. This cohort study is based on an online survey of patients with chronic illness who are recruited in general practitioner (GP) practices in Germany and Italy. After the baseline assessment, participants fill out symptom diaries on 12 specific days of observation over a maximum period of 12 weeks. The specific days of observation are selected based on the maximum temperature that can be expected within the respective weeks. The weather forecast will be checked every Monday. If, in the upcoming 4 days, the maximum temperature is expected to exceed 30°C, the warmest day in this time frame will be chosen. Otherwise, the weather forecast will be checked again on Thursday to choose the warmest of the remaining days of the week. On each day of observation, patients are notified by email at 6 pm. Baseline assessment includes socio-demographic data, chronic diseases, somatosensory amplification, perceived risk for adverse health effects of heat, intention to implement protective behaviour, perceived benefit of this behavior, self-efficacy, and health literacy. Local data on temperatures and humidity will be provided by the meteorological services of Germany and Italy. Data will be analyzed by multivariable, multilevel regression analyses adjusted for possible confounders and random effects on the administration district and practice within administration district level.

Interventions

OTHERNo intervention

No intervention

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER
Claudiana Landesfachhochschule
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* being 18 years or older * at least one of the following conditions: Coronary Heart Disease; Myocardial Infarction; Heart Failure; Cardiac Arrhythmias; Peripheral Artery Disease; Stroke; Transient Ischemic Attack; Diabetes Mellitus (Type 1 or 2); Chronic Obstructive Pulmonary Disease; Asthma; Renal Insufficiency; Depressive Disorder; Anxiety Disorders; Schizophrenia; Peripheral Nervous System Diseases.

Exclusion criteria

* no capacity to consent * severe visual impairment * insufficient German language skills * not able to use internet browser (eg, lack of hardware)

Design outcomes

Primary

MeasureTime frameDescription
Summary score of severity of adverse health effects15 May 2025 to 30 September 2025Observed adverse health effects include nausea, vomiting, tiredness/fatigue, vertigo, circulation problems/syncopes, muscle cramps, headache, extrasystoles, palpitations, edemas, shortness of breath, depressive mood, anxiety, and mental confusion. The severity in each symptom category is defined by the degree of limitations in usual activities from 0=none to 4=very severe. The summary score is calculated by adding the severity of each symptom category.

Secondary

MeasureTime frameDescription
Summary score of participants' implementation of protective behavior against heat15 May 2025 to 30 September 2025Implementation of protective behavior against heat is measured by agreement to nine statements, each rated from 0=not at all to 3=completely. Statements include avoiding exposure to sun and heat (4 items), cooling strategies (2 items), clothing adjustment (1 item), avoiding physical exertion (1 item), and drinking enough (1 item). The summary score is calculated by adding the rating of all nine items.
Self-rated health15 May 2025 to 30 September 2025Subjective health condition on the day of assessment rated by participant on a visual analogue scale between 0 (worst possible) and 100 (best possible).
Level of medical service use15 May 2025 to 30 September 2025Level of service use is ordinally scaled and defined as 0=no service being used, 1=utilization of medical practices, 2=utilization of emergency departments, and 3=utilization of inpatient care. In case of multiple services being used, the highest category is chosen.

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORIngmar Schäfer, PD Dr.

Universitätsklinikum Hamburg-Eppendorf

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026